Real world outcomes on Drug Utilization in Japanese Patients with Crohn's Disease Treated with Adalimumab or Infliximab
Latest Information Update: 27 Oct 2016
Price :
$35 *
At a glance
- Drugs Adalimumab (Primary) ; Infliximab (Primary)
- Indications Crohn's disease
- Focus Therapeutic Use
- 27 Oct 2016 New trial record
- 23 Sep 2016 Results published in the Advances in Therapy